Arsenal Capital Partners completed the acquisition of Cello Health for $237m.

Private equity firm Arsenal Capital Partners completed the acquisition of Cello Health, a healthcare and consumer strategic marketing group, for $237m. "The Cello directors are confident that, as part of the Value Demonstration platform with Arsenal’s backing, Cello will be optimally positioned to accelerate its current strategy and capitalise on a broader range of opportunities. This transaction will ensure the continued success of the business for its employees and clients," Mark Scott, Cello CEO.